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B R I E F  R E P O R T
Association of Inflammation With Pronociceptive Brain 
Connections in Rheumatoid Arthritis Patients With 
Concomitant Fibromyalgia
Chelsea M. Kaplan,1  Andrew Schrepf,1 Eric Ichesco,1 Tony Larkin,1 Steven E. Harte,1 Richard E. Harris,1  
Alison D. Murray,2 Gordon D. Waiter,2 Daniel J. Clauw,1 and Neil Basu3
Objective. Rheumatoid arthritis (RA) patients with concomitant fibromyalgia (FM) exhibit alterations in brain 
 connectivity synonymous with central sensitization. This study was undertaken to investigate how peripheral inflam-
mation, the principal nociceptive stimulus in RA, interacts with brain connectivity in RA patients with FM.
Methods. RA patients with concomitant FM and those without FM (FM+ and FM−, respectively; n = 27 per group) 
underwent functional connectivity magnetic resonance imaging. Seed- to–whole- brain functional connectivity anal-
yses were conducted using seeds from the left mid/posterior insula and left inferior parietal lobule (IPL), which are 
regions that have been previously linked to FM symptoms and inflammation, respectively. The association between 
functional connectivity and erythrocyte sedimentation rate (ESR) was assessed in each group separately, followed by 
post hoc analyses to test for interaction effects. Cluster- level, family- wise error (FWE) rates were considered signifi-
cant if the P value was less than 0.05.
Results. The group of RA patients with FM and those without FM did not differ by age, sex, or ESR (P > 0.2). 
In FM+ RA patients, increased functional connectivity of the insula–left IPL, left IPL–dorsal anterior cingulate, and 
left IPL–medial prefrontal cortex regions correlated with higher levels of ESR (all FWE- corrected P < 0.05). Post 
hoc interaction analyses largely confirmed the relationship between ESR and connectivity changes as FM scores 
increased.
Conclusion. We report the first neurobiologic evidence that FM in RA may be linked to peripheral inflammation 
via pronociceptive patterns of brain connectivity. In patients with such “bottom- up” pain centralization, concomitant 
symptoms may partially respond to antiinflammatory treatments.
INTRODUCTION
Rheumatoid arthritis (RA) is known for its heterogeneous 
clinical presentation, with some patients reporting pain localized 
to affected joints and others reporting widespread hyperalge-
sia, fatigue, and cognitive difficulties. This latter phenotype has 
remarkable similarities to symptoms observed in fibromyalgia 
(FM), and indeed the reported prevalence of concomitant FM in 
RA patients ranges from 12% to 48%, compared to 2–8% in the 
general population (1). Moreover, we recently showed that one of 
the chief neurobiologic signatures of FM (increased default mode 
network [DMN] to insula functional connectivity) also occurs in RA 
patients in proportion to their FM symptoms (2).
In the context of RA, it has long been hypothesized that 
peripheral inflammatory nociceptive processes sensitize the central 
nervous system (CNS) via pronociceptive CNS pathways and drive 
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the occurrence of concomitant FM (3). This suggests that individ-
ual differences in how the brain responds to inflammation may be 
critical to understanding concomitant FM in RA.
We recently provided some of the first evidence that func-
tional brain connections are substantially altered in RA patients 
with high levels of peripheral inflammation (4). In the present study, 
we expanded on that effort by exploring the effect of the interac-
tion between functional brain connectivity and inflammation on 
FM symptoms in the same cohort of RA patients. These analyses 
were designed to identify patterns of brain connectivity in RA that 
promote core symptoms of FM in response to inflammation. We 
hypothesized that higher inflammation would be associated with 
distinct changes in connectivity from the insula (a pronociceptive 
brain region) and left inferior parietal lobule (IPL; a region associated 
with the neural response to peripheral inflammation in RA patients) 
to other brain regions in patients with a high level of FM symptoms.
PATIENTS AND METHODS
Patients. RA patients were approached through a UK 
regional rheumatology service. Patients were considered eligi-
ble if they met the American College of Rheumatology (ACR)/
European League Against Rheumatism 2010 classification cri-
teria for RA (5). This study was designed to examine the neu-
ral correlates of fatigue in RA; therefore, patients had to have 
had a clinically significant level of fatigue for at least 3 months 
(defined as a score of >3 on the Chalder Fatigue Binary Scale 
[6]). The analyses presented in this report address alternate 
hypotheses regarding inflammation and centralized pain in 
RA. Exclusion criteria were contraindications to magnetic res-
onance imaging (MRI), left- handedness, or the presence of 
an alternative medical explanation for fatigue. A total of 73 
RA patients fulfilled these criteria, and 54 patients (41 female) 
completed the entire study. Ethical approval for the study was 
obtained from the North of Scotland Research Ethics Com-
mittee. All participants provided written informed consent in 
accordance with the Declaration of Helsinki.
Clinical evaluation. All consenting patients underwent 
a clinical evaluation and a functional MRI (fMRI) brain scan. FM 
diagnosis was assessed using the ACR modified 2010 criteria 
(7), which combine a measure of widespread pain (number 
of painful sites [range 0–19]) with a symptom severity scale 
(e.g., fatigue, subjective cognitive problems, headache, poor 
mood; scores range from 0 to 12). A combined score of ≥13 
was used as the diagnostic cutoff for FM (7). Twenty- seven RA 
patients met the criteria for FM (FM+), and 27 did not (FM−). 
Inflammation was measured using the erythrocyte sedimen-
tation rate (ESR), a measure of systemic inflammation that is 
commonly used to diagnose and monitor chronic inflamma-
tory diseases such as RA. A trained phlebotomist collected 
venous blood samples during standard clinic hours, and blood 
 samples were immediately processed and analyzed for the 
calculation of ESR (via the Westergren method).
Functional MRI data acquisition and  preprocessing. 
Functional MRI data were collected using an Achieva 3.0T X- series 
MR system (Philips Medical) with an 8- channel phased- array head 
coil. Each patient underwent an 11- minute functional scan while 
performing the Paced Auditory Serial Attention Test (PASAT), a 
validated measure of cognitive function. The PASAT was admin-
istered in a block design with three 3- minute “on” periods, inter-
spersed with four 30- second rest or “off” periods. During the “on” 
periods, a series of numbers were audibly presented, and patients 
were asked to sum consecutive numbers and to press a button 
every time 2 consecutive numbers summed to 10. Concurrently, 
patients were shown a distracting visual stimulus of random, rap-
idly changing numbers that were intended to increase task diffi-
culty. The functional images were acquired using a 3- dimensional 
(3- D) T2*- weighted gradient- echo single- shot echo- planar imag-
ing pulse sequence with the following parameters: repetition time 
(TR) 3,000 msec, echo time (TE) 30 msec, flip angle 90°, in- plane 
Figure  1. A and B, Correlation of higher levels of peripheral 
inflammation with increased brain connectivity between the left mid/
posterior insula (A) and the left inferior parietal lobule (L IPL) (B) in 
rheumatoid arthritis (RA) patients with concomitant fibromyalgia (FM). 
Inset in B shows overlap of the left IPL cluster with previous results (4), 
demonstrating that numerous brain networks were hyperconnected 
to the same region of the IPL in RA patients with high levels of 
inflammation. C, Scatterplots showing correlation between erythrocyte 
sedimentation rate and insula–IPL connectivity in RA patients with 
or without FM; 95% confidence intervals are displayed in red. D, 
Significant positive relationship between insula–left middle frontal gyrus 
(MFG) connectivity and peripheral inflammation in RA patients with FM.
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Sensitivity Encoding (SENSE) acceleration 2, field of view (FOV) 
240 mm, matrix size 128 × 128 pixels with 30 slices, voxel size 
1.88 × 1.88 × 5 mm3, and 226 volumes. A high- resolution struc-
tural T1- weighted fast field- echo 3- D structural scan was collected 
for normalization (TR 8.2 msec, TE 3.8 msec, inversion recovery 
time 1,018 msec, flip angle 8°, FOV 240 mm, matrix size 240 × 
240 pixels with 160 slices, and voxel size 0.94 × 0.94 × 1 mm3).
Functional MRI data were preprocessed using Statistical 
Parametric Mapping (SPM version 8; Wellcome Department of 
Cognitive Neurology, London, UK) running on MatLab R2014a 
(MathWorks), as previously described (2,4). Briefly, the first 4 
volumes were discarded to avoid equilibration effects, and the 
remaining 222 functional images were realigned to the first image. 
The structural image was coregistered to a mean functional image 
and then segmented. The structural and functional scans were 
normalized to the standard SPM Montreal Neurological Institute 
template gray prior probability map via the individuals’ segmented 
gray matter image. Functional scans were then smoothed with an 
8- mm full- width half- maximum Gaussian kernel.
Seed- to–whole brain connectivity analysis. In these 
same RA patients, we have previously shown that DMN–left mid/
posterior insula connectivity is associated with the FM survey 
criteria score (2) and that the left IPL is more connected to mul-
tiple brain networks in patients with high levels of  inflammation 
(4). To determine how FM and inflammation interact in the brain, 
we used these same left insular and IPL clusters as seed regions 
 (Figures  1A and 2A). The preprocessed functional data were 
entered into a Functional Connectivity Toolbox version 15 (CONN; 
 Cognitive and Affective Neuroscience Laboratory, Massachusetts 
Institute of Technology, Cambridge [http://www.nitrc.org/proje cts/ 
conn]). As previously described (2,4), a component-based method 
(CompCor) was performed to remove confounding effects. The 
confounds included 6 subject-specific motion parameters, and the 
signal from white matter and cerebrospinal fluid and their first-order 
derivatives. A band- pass filter (0.01–0.1 Hz) was applied to remove 
linear drifts and high- frequency noise in the data. Task and rest onset 
periods were modeled and concatenated in first- level analyses to 
generate beta maps  representing connectivity between the insula 
and IPL and the rest of the brain during task and rest conditions. 
The resulting beta maps were passed onto second- level group 
analyses in SPM8. Rest periods were not analyzed at the group 
level because the summed resting condition (2 minutes) is too short 
for reliable  connectivity estimates (8).
Using multiple regression models, the FM+ and FM− groups 
were assessed independently in SPM8. In each group we as-
sessed the relationship between seed- to–whole brain connectivity 
and ESR, with age and sex considered covariates of no interest. 
Figure 2. Association of inflammation with functional connectivity in RA patients with concomitant FM. A and B, In RA patients with FM, there 
was a significant relationship between peripheral inflammation and functional connectivity between the left IPL (A) and the dorsal anterior cingulate 
cortex (dACC), medial prefrontal cortex (mPFC), left IPL (adjacent to seed region), right superior frontal gyrus/supplementary motor area (R SFG/
SMA), and right MFG (B). C and D, Scatterplots showing the correlation between erythrocyte sedimentation rate and IPL–mPFC connectivity (C) and 
IPL–dorsal ACC connectivity (D) in RA patients with or without FM; 95% confidence intervals are displayed in red. See Figure 1 for other definitions.
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The resulting maps were thresholded at an uncorrected voxelwise 
level of P < 0.001, and cluster- level family- wise error rates were 
considered significant at P < 0.05 after correction for multiple com-
parisons. The average Fisher- transformed r values of significant 
clusters were extracted from the first- level beta maps for each 
patient for secondary analyses to test for interaction effects.
Post hoc interaction analyses. To formally test the 
possibility of interaction effects, we examined whether the rela-
tionship between connectivity values extracted from significant 
clusters (as described above) and ESR changes as a function of 
total FM scores. Total scores, rather than FM clinical cutoffs, were 
used as we have previously shown that this construct can be 
used continuously (2). ESR and FM survey scores were standard-
ized and centered. These analyses were conducted with general 
linear models in R version 3.4.4. Post hoc Spearman’s rank cor-
relations between functional connectivity and C- reactive protein 
(CRP) level were calculated to confirm the relationships observed 
with ESR.
RESULTS
Clinical characteristics. The clinical characteristics of 
this cohort have been described previously (2,4) and are shown 
for FM+ and FM− groups separately (Supplementary Table 1, 
available on the Arthritis & Rheumatology web site at http:// 
onlin elibr ary.wiley.com/doi/10.1002/art.41069/ abstract). 
Twenty- seven RA patients met criteria for FM. The mean ± SD 
FM score was 17.89 ± 4.77 in the FM+ RA group and 8.52 ± 
3.19 in the FM− RA group. There was no significant difference in 
age, sex, or ESR between FM+ and FM− RA patients.
Seed- to–whole brain connectivity analyses. In FM+ 
RA patients, higher levels of peripheral inflammation were 
associated with increased functional connectivity between the 
insula and the left midfrontal gyrus (MFG) and the left IPL (Fig-
ures 1B–D and Table 1). Further, in FM+ RA patients, higher 
peripheral inflammation was associated with increased func-
tional connectivity between the left IPL and multiple cortical 
regions, including the dorsal anterior cingulate cortex (ACC), 
medial prefrontal cortex (mPFC), right MFG, right superior 
frontal gyrus/supplementary motor area, and left IPL (adjacent 
to the seed IPL region) (Figures  2B–D and Table  1). Of the 
7 connections associated with ESR in FM+ patients, 4 were 
significantly or close to significantly associated with CRP level 
(Supplementary Table 2, available on the Arthritis & Rheuma-
tology web site at http://onlin elibr ary.wiley.com/doi/10.1002/
art.41069/ abstract). In FM− RA patients, higher levels of 
peripheral inflammation were correlated with lower functional 
connectivity between the insula and right IPL and higher func-
tional connectivity between the IPL and left superior temporal 
gyrus (Table 1).
It is possible that other aspects of disease activity, such as 
the swollen and tender joint counts that are incorporated into the 
Disease Activity Score in 28 joints (9), could have been affecting 
our results. We therefore conducted partial correlation analy-
ses between the extracted connectivity values and ESR, while 
controlling for swollen and tender joint counts, separately in the 
FM + and FM− groups. There were no appreciable changes in 
the strength of the association between ESR and connectivity 
in these analyses (data not shown). Additionally, adjustment for 
body mass index did not alter the associations between ESR 
and connectivity in either group (data not shown).
Table 1. Associations between seed- to–whole brain functional connectivity and erythrocyte sedimentation rate*
Seed region  
cluster (direction of association)
MNI coordinates









Left midfrontal gyrus (+) −36 24 32 4.38 161 0.007 0.049
Left IPL (+) −50 −50 40 3.98 132 0.019 0.015
Left IPL
Bilateral dorsal ACC/mPFC (+) 2 38 36 4.43 239 0.001 0.016
Right midfrontal gyrus (+) 30 48 2 4.31 132 0.026 0.317
Bilateral SFG/SMA (+) 8 28 52 4.15 128 0.030 0.040
Right mPFC/right dorsal ACC (+) 12 60 30 3.88 349 0.000 0.002
Left IPL (+)† −32 −48 46 3.76 135 0.023 0.016
Without fibromyalgia
Left insula
Right IPL/precuneus/angular (−) 28 −52 44 4.51 175 0.002 <0.001
Left IPL
Left STG (+) −50 −42 6 4.29 257 0.000 0.024
* MNI = Montreal Neurological Institute; FWE = family- wise error; ACC = anterior cingulate cortex; mPFC = medial prefrontal cortex; 
SFG = superior frontal gyrus; SMA = supplementary motor area; STG = superior temporal gyrus. 
† Adjacent to the seed inferior parietal lobule (IPL) region. 
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Post hoc interaction analyses. There was a significant 
interaction effect between FM scores and ESR for each extracted 
connectivity value except for the left IPL–right MFG (P = 0.317) 
(Table 1). This suggests that the interaction between FM symp-
toms and inflammation is important irrespective of whether a 
patient meets epidemiologic criteria for FM.
DISCUSSION
In RA, peripheral inflammation appears to affect FM status as 
reflected on measures of brain functional connectivity. In our pre-
vious study (2), we demonstrated that a neurobiologic signature 
of pain centralization (enhanced insula–DMN connectivity) is also 
present in RA. Importantly, across the overall sample, this con-
nectivity was not significantly associated with peripheral inflamma-
tion. In this study, we show for the first time that inflammation is 
neurobiologically associated with other more established patterns 
of pronociceptive connectivity in RA, but this is observed only in 
patients with more FM symptoms. These effects were apparent 
when FM was measured as a continuous construct, suggesting 
that FM symptoms may have important neurobiologic correlates 
irrespective of whether a patient meets clinical criteria for FM, as we 
have previously reported (2). This in turn suggests that there is an 
interaction between peripherally enhanced sensitization and cen-
trally maintained sensitization that contributes to FM symptoms in 
RA. Put simply, how the brain responds to peripheral inflammation 
may be critical in understanding why some RA patients have high 
levels of concomitant FM symptoms while others do not.
The insula is a multimodal sensory processing region and is crit-
ically involved in pain perception (10). In FM+ RA patients, increased 
insula–left IPL connectivity was positively correlated with peripheral 
inflammation. The IPL is a key node of the DMN, and heightened 
DMN–insula connectivity is an established neurobiologic feature of 
FM (10), as well as of these same RA patients with high levels of 
FM symptoms (2). In FM+ RA patients, we would expect to see 
increased DMN–insula functional connectivity, but the relationship 
with peripheral inflammation observed in this study is novel. Inter-
estingly, this left IPL region overlapped with the IPL cluster we previ-
ously identified as being more strongly connected to multiple brain 
networks in patients with high levels of peripheral inflammation (4).
Using the IPL cluster from our previous study (4) as a seed 
region, we found that IPL–dorsal ACC and IPL–mPFC functional 
connectivity was positively associated with inflammation only in 
FM+ RA patients. It has been previously shown that during the 
completion of a painful task, FM patients exhibit higher activity in 
the dorsal ACC compared to healthy participants (11). A previous 
study in RA patients demonstrated that the dorsal ACC, mPFC, 
and left IPL were activated during a provoked joint pain paradigm, 
and that the mPFC and left IPL regions were functionally connected 
during this painful task (12). In this context, our results may indicate 
preliminary evidence of the integration of inflammation- linked brain 
connectivity and classic pronociceptive brain connectivity.
In FM– patients, insula–right IPL functional connectivity was 
negatively correlated with peripheral inflammation, while insula–left 
IPL functional connectivity was positively correlated with periph-
eral inflammation in FM+ patients. There is evidence of hemi-
spheric asymmetry in IPL function (13) and in the susceptibility to 
neurodegeneration. For instance, the left hemisphere is affected 
earlier and more severely in Alzheimer’s disease, and the left IPL, 
compared to the right IPL, shows greater metabolic dysfunction 
in early dementia (13). The left IPL may be more susceptible to 
peripherally enhanced sensitization, which is why inflammation- 
associated connectivity changes in this region are predominantly 
observed in patients with concomitant FM.
This is the first study to examine patterns of inflammation- 
associated brain connectivity in the context of concomitant FM 
in RA. Although the evidence is limited, the coexistence of FM 
symptoms with another disorder is thought to constitute 2 broad 
processes: 1) a “bottom- up” form of central sensitization, driven 
primarily by ongoing nociceptive input and somewhat respon-
sive to treatments that target peripheral nociceptive drivers and 
2) a “top- down” central sensitization subtype, which is primarily 
central in origin and unaffected by manipulations of peripheral 
nociception (3). Consistent with this hypothesized distinction, 
a previous osteoarthritis study indicated that successful joint 
replacement surgery resulted in a substantial improvement of 
responses to experimental pain measures outside the surgi-
cal site and that patients whose surgery eliminated their pain 
exhibited a more normal inhibitory response to evoked pain than 
they did prior to surgery (14). In RA, an analogous phenomenon 
would involve improvement in concomitant FM symptoms fol-
lowing successful inhibition of inflammation. Future studies will 
focus on patterns of inflammation- associated brain connectivity 
that predict improvement in concomitant FM after inflammation- 
reducing therapy.
This study has some limitations. First, all of the RA patients 
in the study had significant levels of chronic fatigue, which may 
not necessarily be representative of all patients and could have 
biased the sample toward a centralized pain phenotype. Second, 
we examined functional connectivity during the performance of 
a cognitive task from 2 seed regions based on earlier results 
from the same cohort. Future studies should attempt a whole 
brain agnostic approach in an independent sample in which 
patients are at rest or performing other tasks. We do not know 
when patients developed FM symptoms relative to the onset of 
RA. Therefore, some patients may belong to a different pheno-
type wherein “top- down” central sensitization exists prior to RA 
diagnosis. We have made the reasonable assumption that our 
measure of systemic inflammation (ESR) is derived entirely from 
the well- established peripheral immune dysfunction that char-
acterizes RA. However, considering the evolving evidence that 
supports a neural inflammatory reflex (15), it is also possible that 
altered brain connectivity drives peripheral inflammation, per-
haps via endocrine pathways. It would be intriguing to evaluate 
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the responsiveness of identified pronociceptive connectivity in 
the context of a peripherally directed antiinflammatory treatment, 
as mentioned above.
In a small study on tumor necrosis factor inhibitors (TNFi) in 
RA, Rech et al demonstrated that pronociceptive brain connec-
tivity decreased rapidly (i.e., 3 days) after commencement of TNFi 
treatment and before a positive clinical response was observed 
(16), providing some support for the concept of  “bottom- up” 
sensitization. Ultimately, the great clinical value of distinguishing 
“bottom- up” mechanisms of central sensitization is the potential 
to identify RA patients whose FM symptoms may improve with 
an enhanced peripheral immunosuppressive approach. In con-
trast, “top- down” central sensitization would not be expected 
to respond to peripherally directed therapies. Instead, patients 
may receive benefit from centrally acting interventions. Until 
more definitive studies are conducted, these concepts remain 
as working hypotheses.
Our finding that peripheral inflammation enhances connectivity 
in established pronociceptive pathways provides preliminary neu-
robiologic evidence of a distinct FM- like subtype in RA. Identifying 
the neurobiologic patterns associated with different forms of central 
sensitization of FM in RA may help to refine therapeutic targets.
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